Vaxcyte (PCVX) Treasury Shares (2019 - 2026)

Vaxcyte (PCVX) has 7 years of Treasury Shares data on file, last reported at $3.3 million in Q1 2026.

• On a quarterly basis, Treasury Shares changed N/A year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.3 million, up 1233.57% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.3 million, up from $2.3 million in the prior quarter.
• Over the last five years, Treasury Shares for PCVX reached as high as $3.3 million in Q1 2026 and fell as low as $175513.0 in Q1 2024.
• Historically, Treasury Shares has averaged $1.0 million across 5 years, with a median of $726940.0 in 2023.
• Across the five-year window, Treasury Shares slumped 77.99% in 2024 and jumped 1233.57% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $456766.0 in 2022, then soared by 64.96% to $753462.0 in 2023, then slumped by 76.71% to $175513.0 in 2024, then soared by 1233.57% to $2.3 million in 2025, then soared by 42.27% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.1 million in Q3 2025.